CSIMarket


Johnson and Johnson  (JNJ)
Other Ticker:  
 

Johnson and Johnson

JNJ's Fundamental analysis








Looking into Johnson And Johnson growth rates, revenue grew by 4.95 % in I. Quarter 2022 from the same quarter a year ago. Ranking at No. 2012

Major Pharmaceutical Preparations industry recorded growth of revenues by 19.44 %

Johnson And Johnson's net profit deacreased by -16.91 % in I. Quarter 2022 year on year, to $5,149 millions.

More on JNJ's Growth


Johnson And Johnson
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Johnson And Johnson PEG ratio is at 0.77 Johnson And Johnson realized cash outflow of $ -0.83per share in trailing twelve-month period.
Company
23.85
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.97.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.37.


More on JNJ's Valuation
 
 Total Debt (Millions $) 33,148
 Dividend TTM ($) 4.18 $
 Dividend Yield TTM (%) 2.36 %
 Revenue/Employee (TTM) $ 717,700
 Net Income/Employee (TTM) $ 150,000
 Receivable Turnover (TTM) 6.26
 Tangible Book Value (Per Share $) -1.74

Johnson And Johnson
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Johnson And Johnson PEG ratio is at 0.77 Johnson And Johnson realized cash outflow of $ -0.83per share in trailing twelve-month period.
Company
23.85
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.97.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.37.

Johnson And Johnson Price to Book Ratio is at 6.32 lower than Indusry Avg. of 1282.31. and higher than S&P 500 Avg. of -0.01

More on JNJ's Valuation

  Market Capitalization (Millions $) 471,917
  Shares Outstanding (Millions) 2,667
  Employees 132,200
  Revenues (TTM) (Millions $) 94,880
  Net Income (TTM) (Millions $) 19,830
  Cash Flow (TTM) (Millions $) -2,208
  Capital Exp. (TTM) (Millions $) -3,582
  Total Debt (Millions $) 33,148
  Dividend TTM ($) 4.18 $
  Dividend Yield TTM (%) 2.36 %
  Revenue/Employee (TTM) $ 717,700
  Net Income/Employee(TTM) $ 150,000
  Receivable Turnover Ratio (TTM) 6.26
  Tangible Book Value (Per Share $) -1.74

  Market Capitalization (Millions $) 471,917
  Shares Outstanding (Millions) 2,667
  Employees 132,200
  Revenues (TTM) (Millions $) 94,880
  Net Income (TTM) (Millions $) 19,830
  Cash Flow (TTM) (Millions $) -2,208
  Capital Exp. (TTM) (Millions $) -3,582


    JNJ's Profitability Comparisons
Johnson And Johnson achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2022 to 24.54 % from 19.72 % in IV. Quarter.

Johnson And Johnson net profit margin of 21.98 % is currently ranking no. 27 in Major Pharmaceutical Preparations industry, ranking no. 59 in Healthcare sector and number 813 in S&P 500.


Profitability by Segment
Total Pharmaceutical 57.17 %
Med. Dev. & Diag. 47.39 %
Total Consumer 38.9 %



  Ratio
   Capital Ratio (MRQ) 1.99
  Total Debt to Equity (MRQ) 0.44
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.53
  Inventory Turnover Ratio (TTM) 2.9



Johnson And Johnson achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2022 to 24.54 % from 19.72 % in IV. Quarter.

Johnson And Johnson net profit margin of 21.98 % is currently ranking no. 27 in Major Pharmaceutical Preparations industry, ranking no. 59 in Healthcare sector and number 813 in S&P 500.

More on JNJ's Key Ratios



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GREE's Profile

Stock Price

GREE's Financials

Business Description

Fundamentals

Charts & Quotes

GREE's News

Suppliers

GREE's Competitors

Customers & Markets

Economic Indicators

GREE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071